That is the abbreviated CSR. Neither that nor the actual study protocol tell you what the actual investigational product is composed of aside from mentioning proprietary technology borrowed from a German lab, which they don't get into at all in the protocol. The protocol is THE document used to conduct all aspects of the trial, you don't leave the descritpion of the drug out, nor do you tell people to reference other literature to find out what the drug is. And the NEJM is compromised. It is no longer an unbiased scientific publication.